West Pharmaceutical Services, Inc.
As of Oct 23, 2026 close
- Market cap
- $27.96B
- P/E (TTM)
- 49.50
- Forward P/E
- 43.51
- Dividend yield
- 0.22%
- 52-week range
- $223.83$389.75
- Volume (live)
- -
- Avg. volume (3M)
- 581.56K
West Pharmaceutical Services (WST) Stock Price & Financial Analysis
West Pharmaceutical Services Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $389.72 - $394.18 |
|---|---|
| 52-Week High | $389.75 |
| 52-Week Low | $223.83 |
| Open | $391.60 |
| Volume (last close) | 718.05K |
| Average Volume (3M) | 581.56K |
| Revenue (TTM) | 3.33B |
|---|---|
| Net Income (TTM) | 564.90M |
| Free Cash Flow (TTM) | 436.90M |
| EPS (TTM) | $7.82 |
| Profit Margin | 16.98% |
| Operating Margin | 21.04% |
| Return on Equity (ROE) | 18.89% |
| Debt to Equity | 0.07 |
| Annual Dividend | $0.88 |
|---|---|
| Dividend Yield | 0.22% |
| Payout Ratio | 11.26% |
| Next Dividend Ex-Date | Nov 10, 2026 |
| Market Cap | 27.96B |
|---|---|
| Shares Outstanding | 71.30M |
| P/E Ratio (TTM) | 49.50 |
| Forward P/E | 43.51 |
| Price to Sales (P/S) | 8.40 |
| Price to Book (P/B) | 9.35 |
| EV/EBITDA | 31.98 |
| 50-Day MA | $359.47 |
|---|---|
| 200-Day MA | $308.39 |
| 1-Year Change | +28.24% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
West Pharmaceutical Services at a Glance
As of the Oct 23, 2026 close, West Pharmaceutical Services (WST) has a market capitalization of $27.96B. The stock trades at 49.5× trailing earnings, 43.5× forward earnings and 8.4× sales. Over the trailing twelve months it earned $564.90M on revenue of $3.33B (a 17.0% profit margin) and generated $436.90M of free cash flow. Revenue grew 12.4% year over year.
As of its latest reported balance sheet, it holds $435.80M in cash and securities against $223.80M of debt, a net cash position of $212.00M.
West Pharmaceutical Services pays a quarterly dividend totaling $0.88 per share a year, a 0.22% yield at the Oct 23, 2026 close, with a 11% payout ratio and 33 consecutive years of dividend increases.
The share price is up 28.2% over the past year. At $392.15 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $223.83 to $389.75, above its 200-day moving average of $308.39.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $418.67, 6.8% above the Oct 23, 2026 close.
Frequently Asked Questions About West Pharmaceutical Services
What is the current stock price for WST?
As of the Oct 23, 2026 close, WST stock trades at $392.15. The 52-week range is $223.83–$389.75, with a day range of $389.72–$394.18.
What is the P/E ratio for WST?
As of the Oct 23, 2026 close, West Pharmaceutical Services's trailing twelve-month (TTM) P/E ratio is 49.5, meaning investors pay $49.5 for every $1 of annual earnings. The forward P/E is 43.5, reflecting analyst expectations for future earnings. West Pharmaceutical Services operates in the Healthcare sector.
Does WST pay dividends?
Yes, West Pharmaceutical Services pays a 0.22% annual dividend yield as of the Oct 23, 2026 close ($0.88 per share a year). The trailing twelve-month payout ratio is 11.3%. The next ex-dividend date is November 10, 2026.
What do analysts recommend for WST?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for WST is Buy. The average 12-month price target is $418.67, a 6.8% upside from the Oct 23, 2026 close of $392.15.
What is the market cap of WST?
As of the Oct 23, 2026 close, West Pharmaceutical Services's market capitalization is $27.96B, classifying it as a large-cap company. West Pharmaceutical Services operates in the Healthcare sector within the Medical Instruments & Supplies industry.